Companion Diagnostics

Companion diagnostics help healthcare professionals determine which patients are suitable candidates for a particular medication or therapy, ensuring that the treatment is personalized and targeted to those who will derive the most benefit. Companion diagnostics play a significant role in fields such as oncology, where targeted therapies are becoming increasingly important. They enable healthcare professionals to match patients with the most appropriate targeted therapies based on their molecular profile, enhancing the chances of successful treatment. Additionally, companion diagnostics can also be utilized in other areas of medicine, such as infectious diseases, cardiovascular disorders, and autoimmune conditions, among others.

Gas chromatography is a versatile analytical technique that can separate and analyze volatile compounds present in a sample. In the context of companion diagnostics, GC can be employed to identify and quantify specific biomarkers or genetic markers that are relevant to the diagnosis, prognosis, or treatment response of a particular disease or condition. The use of gas chromatography in companion diagnostics offers several advantages. It provides a highly sensitive and specific method for identifying and quantifying biomarkers, enabling accurate diagnostic information.